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Service readiness for inpatient care of 
small and sick newborns: what do we 
need and what can we measure now?
Background Each year an estimated 2.6 million newborns die, 
mainly from complications of prematurity, neonatal infections, and 
intrapartum events. Reducing these deaths requires high coverage 
of good quality care at birth, and inpatient care for small and sick 
newborns. In low- and middle-income countries, standardised 
measurement of the readiness of facilities to provide emergency ob-
stetric care has improved tracking of readiness to provide care at 
birth in recent years. However, the focus has been mainly on ob-
stetric care; service readiness for providing inpatient care of small 
and sick newborns is still not consistently measured or tracked.
Methods We reviewed existing international guidelines and re-
sources to create a matrix of the structural characteristics (infra-
structure, equipment, drugs, providers and guidelines) for service 
readiness to deliver a package of inpatient care interventions for 
small and sick newborns. To identify gaps in existing measurement 
systems, we reviewed three multi-country health facility survey 
tools (the Service Availability and Readiness Assessment, the Ser-
vice Provision Assessment and the Emergency Obstetric and New-
born Care Assessment) against our service readiness matrix.
Findings For service readiness to provide inpatient care for small 
and sick newborns, our matrix detailed over 600 structural char-
acteristics. Our review of the SPA, the SARA and the EmONC as-
sessment tools identified several measurement omissions to capture 
information on key intervention areas, such as thermoregulation, 
feeding and respiratory support, treatment of specific complications 
(seizures, jaundice), and screening and follow up services, as well 
as specialised staff and service infrastructure.
Conclusions Our review delineates the required inputs to ensure 
readiness to provide inpatient care for small and sick newborns. 
Based on these findings, we detail where questions need to be add-
ed to existing tools and describe how measurement systems can be 
adapted to reflect small and sick newborns interventions. Such 
work can inform investments in health systems to end preventable 
newborn death and disability as part of the Every Newborn Action 
Plan.
Electronic supplementary material: 
The online version of this article contains supplementary material.
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The first 28 days of life, the newborn period, represents the time of highest risk in the human lifecycle. 
In 2016, an estimated 2.6 million newborns died [1], mainly of complications of prematurity (35%), in-
fections (23%), and intrapartum complications leading to birth injury (24%) [1,2]. Preventing deaths 
from these causes requires a combined health systems approach [3] along the continuum of care. This 
approach should deliver routine newborn care for all babies (cleanliness, thermal care and support for 
breastfeeding), newborn resuscitation and prevention of mother to child transmission of HIV (PMTCT) 
for all babies who need it [4,5]; and timely provision of quality inpatient care for babies born small and 
sick [6,7].
Many low birth weight newborns, especially preterm infants, and those born small for gestational age, 
require support to feed and maintain their temperature. In addition, preterm newborns face increased 
risks of respiratory problems, infections and jaundice [8]. Even amongst those born at full term, signifi-
cant numbers of newborns suffer from systemic infections, neonatal encephalopathy, pathological jaun-
dice and congenital abnormalities, with high mortality risk in the absence of care [8]. “Small and sick 
newborns”, therefore, includes all those babies who require inpatient (facility-based) care to survive. The 
care that small and sick newborns require is not an individual intervention, but a package made up of 
multiple interventions. Previous work has discussed the specific evidence-based interventions that com-
prise this package of care [3,8,9], which are displayed in Figure 1.
Figure 1. Evidence-based newborn care interventions from basic to complex care. There are additional evi-
dence-based interventions for newborns that should be included in the antenatal period – antenatal corticosteroids 
and antibiotics for preterm premature rupture of membranes – and follow-up processes that would fall outside of 
the newborn period and be linked to paediatric services. Figure adapted from [8]. Photo credit (from top to 
bottom) Ayesha Vellani/Save the Children, ©EFCNI, JHPIEGO.
Delivery of interventions to small and sick newborns requires health facilities that are prepared, which is 
termed as “service readiness”. The underpinning principle to service readiness is based on traditional 
quality of care frameworks, such as that conceived by Donabedian (Figure 2). The framework refers to 
the structures (the necessary infrastructure, equipment, drugs, health providers and guidelines); and pro-
cesses (actions performed by health professionals with requisite training and skills) that are needed to 
provide a package of care [8]. When all of the components of the structural domain are in place, it allows 
for improvements in clinical processes, which in turn lead to improvements in patient outcomes [10-12]. 
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To achieve service readiness, the structures not only need to be present, but maintained, re-stocked 
and updated (eg, equipment requires maintenance, supplies require re-stocking, guidelines require 
updating) and staff continually trained and supervised. To deliver a quality package of care, there-
fore, requires strong health systems with the capacity to monitor and track service readiness and re-
act appropriately to service needs.
Evidence from The Lancet Every Newborn Series [13] informed the design of the Every Newborn Ac-
tion Plan, a multi-partner initiative launched in 2014, backed by a World Health Assembly Resolu-
tion. Every Newborn aims to end preventable newborn deaths and stillbirths, with national targets of 
≤12 neonatal deaths per 1000 live births and ≤12 stillbirths per 1000 total births by 2030 [7]. To 
achieve these targets, Every Newborn partners acknowledge a need to improve the measurement of 
care at birth, and to better track coverage, quality, and equity of care for small and sick newborns 
around the time of birth [14]. A dedicated sub-group – Every Newborn metrics - focuses on improv-
ing the measurement of interventions [14], and has a work stream focused on service readiness for 
inpatient care of small and sick newborns [9].
Currently, national and facility-based health information systems in low- and middle-income coun-
tries collect few data on service readiness for small and sick newborns [13-15], in contrast with child 
health programmes, notably immunisation, HIV and malaria [16]. Data are sparse in sub-Saharan 
Africa and parts of Asia where access to care for small and sick newborns is the lowest, and where 
many facilities need targeted efforts to strengthen services [8,14].
Data from functional routine national health management information systems (HMIS) and logistics 
management systems (LMIS) are able, in principle, to capture service readiness in a sustainable way, 
but the content and quality of data in national HMIS are variable in practice. This means many low- 
and middle-income countries depend on periodic evaluations, such as nationally representative fa-
cility surveys or censuses, as a key source of health information to monitor the readiness of the health 
system to provide facility-based care [14,17,18]. These surveys or censuses are referred to as health 
facility assessments.
The most common health facility assessment tools are the Demographic and Health Survey Pro-
gramme’s Service Provision Assessment (SPA), the WHO Service Availability and Readiness Assess-
ment (SARA) [19,20], and the EmONC assessments, currently managed by Averting Maternal Death 
and Disability (AMDD) [21] in collaboration with UNFPA [22]. The content of these tools with re-
gards to service readiness specifically for inpatient care of small and sick newborns has not previous-
ly been systematically evaluated.
Our overall aim was to review the current health facility assessment tools’ ability to capture service 
readiness for inpatient care of small and sick newborns.
Figure 2. The Donabedian framework applied as a construct to map health facility assessment tools.
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The specific objectives of this article are to:
1.  Create a standardised matrix of the structural components (infrastructure, equipment, 
drugs, providers and guidelines) required to deliver inpatient care for small and sick new-
borns.
2.  Compare the components of this standardised matrix against what is currently measured 
by widely used multi-country health facility survey tools (SPA, SARA, EmONC assess-
ment) and identify gaps in measurement of the structural and process domains.
3.  Synthesise these findings to provide recommendations on how to improve measurement 
of service readiness for inpatient care of small and sick newborns.
METHODS
Conceptual framework for service readiness
We applied the Donabedian framework [10,11] as a construct to map service readiness for small and sick 
newborns (Figure 2).
For the first objective, we mapped the structural domain of the framework and identified the infrastruc-
ture, equipment, drugs, health providers and guidelines required to deliver inpatient care for small and 
sick newborns. The second domain in the framework (process) links structures and outcomes, and is 
dealt with in objective 2.
Objective 1: Create a standardised matrix of structural components 
Development of matrix of service readiness requirements for inpatient care of small and sick 
newborns
We listed a total of 17 newborn interventions based on work done previously as part of the Every New-
born metrics process [5,8,23] (Figure 1). All newborn interventions were included for this exercise, in-
cluding essential newborn care, based on the rationale that small and sick newborns will require these 
basic interventions in addition to inpatient care [8,9].
We organised the matrix by six areas: 1) labour and delivery room 2) place of care for small and sick new-
borns 3) pharmacy/medicines, 4) human resources/providers, 5) laboratory & blood bank and 6) referral 
service. We organised interventions by whether they occur in the labour and delivery room or the neo-
natal unit (or both). Human resources and pharmacy were allocated as a separate area given that provid-
ers and drugs will be needed in multiple places of care. Given that most of the guidelines reviewed in-
cluded information or guidance on referral systems and the associated structural components, we 
included referral system as a separate “area”. Finally, given the wide variation in laboratory systems, we 
separated the laboratory and blood bank by capacity to perform certain tests and actions, rather than an 
itemised list of components or equipment.
We searched for existing published guidelines for all the newborn interventions, including relevant new-
born and paediatric guidelines available on the WHO website. Where no WHO guideline existed, we 
consulted relevant resources developed by UNICEF and other partners, including resources from inter-
national professional associations, such as the American Academy of Paediatrics and Royal College of 
Paediatrics and Child Health. To ensure consistency with other areas of care, we also reviewed the inter-
agency list of medical devices for essential interventions for reproductive, maternal, newborn, and child 
health [24], a master list created for newborn health in humanitarian settings by the Inter-Agency Work-
ing Group on Reproductive Health in Crises (IWAG), UNICEF and Save the Children [25] and the latest 
version of the WHO model essential drugs list [26]. See Table 1 for a list of the guidelines and resources 
used for this review.
Within each area of the matrix, where equipment items recurred (eg, components required for more than 
one intervention such as linen, gauze, swabs, weighing scale) we included these under general items for 
either the labour and delivery room or place of care for small and sick newborns. We were then able to 
populate the matrix with the specific components required to deliver the interventions for small and sick 
newborns.
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Objective 2: Compare the components of this standardised matrix against 
widely used multi-country health facility survey tools (SPA, SARA, EmONC 
assessment) and identify gaps in measurement of structural and process 
domains
We obtained the latest versions of the SARA (version 2.2, revision July 2015) [20] and the SPA (revised 
2012) [27] from their websites. The EmONC assessment tool was being revised at the time of the study 
and we obtained the version undergoing field-testing from AMDD in July 2016.
We reviewed the SARA core questionnaire tool, the SPA health facility inventory and health worker in-
terview, and the latest versions of the relevant modules from the EmONC assessment, (Module 1: Iden-
tification of facility and infrastructure; Module 2: Human Resources; Module 3: Essential drugs, equip-
ment and supplies; Module 5: EmONC interventions; and Module 7: Provider knowledge and 
competency for maternal & newborn care).
We compared the content of each of the tools to the structural components in our matrix. To identify 
gaps in structural components we checked:
•  Does the tool measure the infrastructure, equipment, drugs, health providers and/or 
guidelines needed to provide the interventions?
Many of the tools are designed to also measure aspects of the process domain in the service readiness 
framework (Figure 2). Therefore, measurement of regular practice or training was considered as a proxy 
measurement of the process domain for service readiness (as it looks at what is regularly done to patients 
Table 1. Resource materials and guidelines reviewed for newborn interventions
InterventIon resource materIal or guIdelIne Year publIshed
Essential newborn care, 
thermal protection, early 
initiation and support for 
exclusive breastfeeding
WHO essential newborn care course 2010
WHO early essential newborn care: Clinical practice pocket guide 2014
Essential care for every baby 2015
WHO Integrated management of pregnancy and childbirth: Pregnancy, Childbirth, Postpartum and 
Newborn Care: A guide for essential practice
2015
UNICEF: Baby Friendly Hospital Initiative (BFHI) 2012
WHO Interagency list of priority medical devices for essential interventions for reproductive, maternal, 
newborn and child health
2015
Neonatal resuscitation
WHO guidelines on basic newborn resuscitation 2012
Helping Babies Breathe Resources 2017
WHO guidelines on managing complications in pregnancy and childbirth 2007
WHO guidelines on managing newborn problems: a guide for doctors, nurses and midwives 2003
Prevention of mother to child 
transmission of HIV
WHO guideline update on HIV and infant feeding 2016
WHO guidelines on antiretroviral drugs for treating pregnant women and preventing HIV infection 
in infants
2010
Médecins sans Frontières: Neonatal Care Guidelines 2016
Kangaroo mother care for 
premature babies, including 
follow up, alternative feeding 
(cup feeding and nasogastric 
feeding)
Essential care for small babies 2015
WHO kangaroo mother care: A practical guide 2003
WHO guidelines on optimal feeding of low birth-weight infants in low- and middle-income countries 2011
UNHCR operational guidelines on improving newborn health in refugee operations 2014
UNICEF toolkit for setting up special care newborn units, stabilisation units and newborn care corners 2015
WHO recommendations on interventions to improve preterm birth outcomes
Injectable antibiotics for 
neonatal infections, hypogly-
caemia management, effective 
phototherapy, seizure 
management, administration 
of oxygen
WHO pocket book of hospital care for children 2013
Save the Children, UNICEF: Newborn care charts 2009
Treatment and screening for 
retinopathy of prematurity*
Guidelines on screening and treatment for retinopathy of prematurity (UK and India) 2008
Blood transfusion, Mechanical 
ventilation and continuous 
positive airway pressure 
(CPAP)
WHO pocket book of hospital care for children 2013
*No current WHO guidelines available; recent guidelines recommended by ROP experts from India and UK selected for review.
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in the institution). For each of the 17 interventions included in the package of care (Figure 1), we also 
checked:
• Does the tool measure whether staff are given any training to provide the intervention?
• Does the tool measure if the intervention is regularly performed?
The first author (SM), conceptualised the matrix and completed the review of each tool. The matrix was 
then verified for completeness by practicing neonatologists and nurses with experience in neonatal care 
in Ghana, Nigeria and co-author practicing neonatal clinicians with experience in India, Malawi, Ugan-
da, United Kingdom and United States.
The review of the health facility assessment tools was verified by a representative of the lead agency for 
the EmONC assessment and the SPA to ensure the findings were consistent with the most recent versions 
of the tool.
RESULTS
Objective 1: Create a standardised matrix of structural components 
We mapped a total of 654 service readiness items for inpatient care of small and sick newborns to pro-
vide 17 interventions. This included a total 167 structural items in the labour and delivery room and 266 
in the place for small and sick newborn care (or neonatal unit). We listed a total of 33 different potential 
providers, 114 essential newborn drugs and medicines. A summary list of the international resource ma-
terials and guidelines available for care of small and sick newborns used for this objective is included in 
Table 1. The essential drug list is shown in Table 2. The complete matrix is available in the supplemen-
tary material (Table S1 in Online Supplementary Document).
Table 2. Example minimum drug list for inpatient care of small and sick newborns showing rationale for use in newborns and 
summary of the Service Provision Assessment (SPA), Service Availability and Readiness Assessment (SARA) and Emergency Obstetric 
and Newborn Care (EmONC) Assessment tools and Essential Medicines list*
drug name spa sara emonc eml drug descrIptIon/use
Antibiotics:
Amoxicillin (oral suspension) Y Y Y Y Penicillin antibacterial for neonatal infections
Amoxicillin (injection) Y Y Penicillin antibacterial for serious neonatal infections
Amikacin (IV or IM) Y
Aminoglycoside antibacterial; alternative treatment of opthalmia 
neonatorum
Ampicillin (IV or IM) Y Y Y Y Penicillin antibacterial for serious neonatal infections
Ampicillin (oral) Penicillin antibacterial for neonatal infections
Azithromycin (oral) Y Y Y Macrolide antibacterial for P-PROM (maternal use)
Benzathine benzylpenicillin (benzathine 
penicillin G) (IM)
Y Y Y Penicillin antibacterial for treatment of congenital syphilis
Benzylpenicillin (Penicillin G) (IV or IM) Y Y Y Penicillin antibacterial for serious neonatal infections
Cefalexin (oral suspension) Y
First generation cephalosporin used in newborns for skin and soft tissue 
infections
Cefotaxime (IV or IM) Y Y
First generation cephalosporin with broad spectrum for treatment of 
serious neonatal infections
Ceftriaxone (IV or IM) Y Y Y
Third generation cephalosporin for neonatal infections, genital gonococcal 
and/or chlamydial infection
Ciprofloxacin (injection) Y
Second generation fluoroquinolone antibacterial sometimes used as 
second line treatment
Ciprofloxacin (oral) Y Y Y
Second generation fluoroquinolone antibacterial for treatment of bacterial 
diarrhoea
Clindamycin (IV) Y Y
Lincosamide antibacterial, second line treatment (eg, streptococcal or soft 
tissue infections)
Co-amoxiclav (oral suspension) Y Penicillin antibacterial, can be used where no IV access
Co-amoxiclav (injection) Penicillin antibacterial used for neonatal skin infections
Cotrimoxazole (oral) Y Y Combined antibacterial for prophylactic treatment of HIV
Erythromycin (oral) Y Y Y Macrolide antibacterial for P-PROM (maternal use)
Flucloxacillin (IV/IM) (cloxacillin) Y Y Penicillin antibacterial treatment for neonatal sepsis
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drug name spa sara emonc eml drug descrIptIon/use
Flucloxacillin (oral) Y Y
Penicillin antibacterial. Can be used in newborns as follow on from 
intravenous flucloxacillin
Gentamicin (IM or IV) Y Y Y Y Aminoglycoside antibacterial used for treatment of neonatal sepsis
Isoniazid (oral) Y Y Y Antituberculous antibacterial used occasionally for congenital TB
Kanamycin Y Aminoglycoside antibacterial; alternative to gentamicin
Metronidazole (IV) Y Y Y Y
Antiprotozoal antibacterial used for neonatal meningitis and/or anaerobic 
bacterial infections
Metronidazole (oral) Y Y Y
Antiprotozoal antibacterial used for neonatal meningitis and/or anaerobic 
bacterial infections
Procaine benzylpenicillin (IM) Y Y Y Penicillin antibacterial used for congenital syphilis
Tetracycline 1% eye ointment Y Y Y Y
Prophylactic topical antibiotic used to prevent bacterial (eg, chlamydial, 
gonococcal) neonatal conjunctivitis
Anticonvulsants:
Diazepam (oral/NG) Y Sedative, anticonvulsant, muscle relaxant mostly used for neonatal tetanus
Diazepam emulsion (IV) Y Y Y Y Sedative, anticonvulsant, muscle relaxant, used for neonatal tetanus
Midazolam (oral solution) Y Sedative, anticonvulsant used for seizures
Paraldehyde (rectal) Anticonvulsant for seizures
Phenobarbital (IV or IM) Y Y Y First line anticonvulsant for tonic clonic and partial seizures
Phenobarbital (oral) Y Y First line anticonvulsant for tonic clonic and partial seizures
Phenytoin (IV) Y Y Anticonvulsant for tonic clonic and partial seizures
Emergency drugs:
Adrenaline/epinephrine (IV) Y Y Y Y
Sympathomimetic for cardiopulmonary arrest used for advanced neonatal 
resuscitation
Aminophylline Y Methylzanthine used to prevent apnoeic attacks in premature newborns
Atropine (injection) Y Y Y Parasympatholytic, antispasmodic used for intubation
Calcium gluconate (injection) Y Y Y Y Used for hypocalcaemic seizures and hyperkalaemia
Hydrocortisone (injection) Y Y Y
Steroidal anti-inflammatory used for hypotension or severe broncho-
pulmonary dysplasia
Magnesium sulphate (IV) Y Y Y Y
Inorganic salt compound, maternal use in preterm labour, protective 
against cerebral palsy
Naloxone (IV) Y Y Specific opioid antagonist for respiratory depression in newborns
Analgesics:
Ibuprofen (IV) Y
Analgesic sometimes used in newborns for closing patent ductus 
arteriosus
Morphine (IV) Y Y Y Centrally acting opioid analgesic for severe pain, sedation and intubation
Morphine (oral) Y Y Y Used for severe pain
Paracetamol (oral) Y Y Y Y Analgesic for minor pain
Paracetamol (suppository) Y Analgesic for minor pain
Paracetamol (injection)
Analgesic for minor pain. Also used for newborns for closing patent 
ductus arteriosus.
Corticosteroids:
Betamethasone (IM) Y Y Y
Not used in newborns; used in mothers with threatened preterm labour 
<34 weeks gestation for fetal lung maturation
Dexamethasone (IM) Y Y Y Y
Not used in newborns; used in mothers with threatened preterm labour 
<34 weeks gestation for fetal lung maturation
IV fluids:
Calcium gluconate 10% Y Y Y
Supplement used to treat calcium deficiency. Dependent on programme 
context – careful monitoring required
Dextrose 10% with normal saline Y Y Y Solution used for maintainance fluid therapy
Dextrose/glucose 5% Y Y Y Y Solution used as vehicle for administration of IV drugs
Dextrose/glucose 10% Y Y Y
Solution for treatment of hypoglycaemia and maintenance fluid therapy 
on first day of life for sick babies who cannot feed
Potassium chloride (KCl) 7.5%, 10%, 
15%
Y
Solution only to be used in contexts where monitoring of potassium levels 
is available.
Sodium bicarbonate Y Solution used to dissolve artesunate
Sodium chloride 0.9% Y Y Y Y
Solution used as a vehicle for administration of IV/parenteral drugs, fluid 
replacement and flushing IV lines
Ringer’s lactate Y Y Y Y
Compound solution for severe dehydration/hypovolaemia can be added to 
dextrose/glucose for a mix
Water for injection Sterile water for mixing drugs
Table 2. Continued
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drug name spa sara emonc eml drug descrIptIon/use
Anti-malarials:
Artesunate (IV or IM) Y Y Y First line treatment for neonatal malaria
Artesunate (rectal) Y Y Y Neonatal malaria treatment if IV/IM access not available
Arthemeter (IM) Y Second line treatment for neonatal malaria
Artemisinin-based combined therapy 
(oral)
Y Y Y Y Second line anti-malarial treatment followed by ACT
Antiretrovirals (may vary depending on national HIV guidelines):
Azidothymidine/Zidovudine (AZT) (oral) Y Y Y Y Antiretroviral
Lamivudine Y Y Y Y Antiretroviral
Nevirapine (NVP) (oral) Y Y Y Y Antiretroviral
Other drugs:
Aciclovir (IV) Y Antiviral used for herpes
Acyclovir 3% topical eye ointment Y
Antiviral active against herpes virus used to prevent neonatal herpes 
keratitis in babies born to mother with genital herpes
Anti-Rho (D) immune globulin 
(injection) *
Y
To prevent Rhesus disease (haemolytic disease of the newborn), given to 
mothers
Caffeine citrate (oral) Y Preventive treatment for apnoea
Caffeine citrate (IV) Y Preventive treatment for apnoea, oral preferred over IV
Chlorhexidine digluconate 7.1% gel 
(delivering 4% chlorhexidine)
Y Y Y Topical treatment of omphalitis
Domperidone Anti-reflux drug for gastro-oesophageal reflux
Ethambutamol (oral) Y Y Y First line oral anti-tuberculolous drug
Ferrous fumerate (oral) Y Y Y Oral suspension used for preterm neonates to prevent iron deficiency
Folic acid Y Y Y Y Oral suspension used for folate supplementation
Fluconazole (IV) Y Antifungal drug used in newborns over 1 week
Fluconazole (oral) Y Y Y Y Antifungal drug
Furosemide (IV) Y Y Diuretic used for chronic lung disease, oedema in advanced settings
Furosemide (oral) Y Y Y Diuretic
Glycerin chip Suppository used in newborns to stimulate stooling
Hepatitis B immune globulin (HBIG) Treatment of Hepatitis B in neonates
Human milk fortifier
Fortifier, adds protein, calories and micronutrients to expressed breastmilk 
for LBW babies
Insecticxide treated bed nets (in malaria 
endemic areas)
Y Y Y For mother’s beds in KMC ward and for discharge home
Lidocaine solution Y Y Y Y Local anaesthetic
Miconazole cream (or equivalent eg, 
gentian violet)
Y Y Topical antifungal for candida dermatitis used for nappy area
Multivitamin Containing zinc, vitamin A etc.
Nystatin (oral solution) Y Y Y
Topical antifungal for oropharyngeal candidiasis used prophylactically 
with antibiotic treatment
Nystatin cream Y Topical antifungal
Omeprazole (IV) Y Y Acid blocker for gastro-oesophageal reflux
Omeprazole (oral) Y Y Acid blocker for gastro-oesophageal reflux
Oral rehydration solution Y Y Y Y
Powder to mix with drinking water for oral rehydration; breastmilk 
feeding should be encouraged
Oxygen supply Y Medical inhalation gas for treatment of respiratory distress
Phosphate and calcium supplements Supplementation
Potassium Chloride (1mmol/ml) (oral) Y Powder solution for maintainance oral potassium replacement
Pyridoxine (oral) Y Preventive therapy for tuberculosis
Pyrazinamide (oral) Y Y Y First line oral anti-tuberculolous drug
Ranitidine (IV) Y Antacid drug for gastro-oesophageal reflux
Ranitidine (oral) Y Antacid drug for gastro-oesophageal reflux
Rifampicin (oral) Y Y Y First line oral anti-tuberculolous drug
Sucrose 30% (oral)
Non-pharmacological pain management for minor procedures (eg, 
cannulation)
Tetanus immunoglobulin (HTIG) (IM) Y Y Anti-tetanus immunoglobulin for treatment of neonatal tetanus
Vitamin B6 (pyridoxine) (IV or IM) Vitamin for B6 deficiency
Vitamin D Supplementation.
Vitamin K1 (Phytomenadione) (IM or IV) Y Y
Vitamin and anti-haemorrhagic for prophylactic treatment of 
haemorrhagic disease of the newborn
Table 2. Continued
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Objective 2: Compare the components of this standardised matrix against widely 
used multi-country health facility survey tools (SPA, SARA, EmONC assessment) 
and identify gaps in measurement of structural and process domains
The SPA, the SARA and the EmONC assessment tools are summarised in Table 3. All three tools have 
different purposes, are measured at different intervals, and have different approaches to measurement and 
sampling.
drug name spa sara emonc eml drug descrIptIon/use
Water based lubricant For inserting suppositories and/or other procedures.
Zinc oxide cream Topical for nappy/diaper rash
Vaccines:
BCG vaccine Y Y Y Y Prevention of TB
Diptheria Y Y Y Prevention of diptheria
Pertussis vaccine Y Y Y Prevention of pertussis
Haemophilus influenzae type b (Hib) 
vaccine
Y Y Y Prevention of haemophilis influenzae type B
Hepatitis B vaccine Y Y Y
Prevention of hepatitis B in countries where perinatal infection is 
common, as per vaccination schedule
Oral poliomyelitis vaccine Y Y Y Y Prevention of poliomyelitis
Tetanus toxoid Y Y Y Y
Prevention of tetanus in wound management, prevention of maternal and 
neonatal tetanus in pregnant women
EmONC – Emergency Obstetric and Newborn Care, SPA – Service Provision Assessment, SARA – Service Availability and Readiness Assessment, EML 
– Essential Medicines List, IM – intramuscular, IV – intravenous, NG – nasogastric
*Y – measured by the tool.
Table 2. Continued
Table 3. Summary of three multi-country health facility assessment tools: Service Provision Assessment (SPA), Service Availability 
and Readiness Assessment and Emergency Obstetric and Newborn Care (EmONC) Assessment
servIce provIsIon assessments (spa) servIce avaIlabIlItY and readIness assessment (sara)
emergencY obstetrIc and newborn care (emonc) 
assessment
Purpose of tool
For comprehensive monitoring of a 
country’s formal health care system; 
monitors the overall availability of dif-
ferent facility-based health services in a 
country and their readiness to provide 
those services
For assessing readiness of facilities using a 
standard set of indicators that cover all 
main health programmes. Only designed to 
assess service readiness (not performance 
or client perspectives)
For monitoring and assessment of the avail-
ability, use and quality of routine and emergen-
cy obstetric and newborn care in the formal 
health system.
Organisation(s)
The Demographic and Health Survey 
(DHS) Program, United States Agency 
for International Development (USAID)
World Health Organization (WHO), US-
AID
Averting Maternal Death & Disability (AMDD), 
United Nations Population Fund (UNFPA), 
United Nations Children’s Fund (UNICEF), 
WHO.
Sample
Sample survey or census of formal sec-
tor health facilities designed to provide 
nationally representative results by fa-
cility type, managing authority, and 
geographic region.
Sample survey or census of at least 150 
public and private facilities
Census of hospitals and census or sample of 
lower-level delivery sites (public and private 
facilities). Sample may be random or selection 
may be restricted to lower-level facilities that 
meet a specific volume of deliveries.
Modules
Facility inventory, exit interviews (ante-
natal care, family planning, sick child), 
clinical observations (antenatal care, 
family planning, sick child), health 
worker provider interviews
Facility inventory, health worker interview Facility inventory, human resources, essential 
drugs, equipment and supplies, facility case 
summary, Emergency Obstetric Care (EmOC) 
signal functions, provider knowledge for mater-
nal and some newborn care & chart reviews.
Numerator for 
indicator
Number of facilities ready to provide 
MNCH, family planning, HIV/AIDS, 
STIs, Malaria, Tuberculosis, basic sur-
gery, non-communicable diseases ser-
vices.
Proportion of health facilities, number of 
core medical professionals, proportion of 
facilities offering a defined service and the 
density and distribution of the facilities
Number of facilities providing EmOC, number 
of facilities providing each EmOC signal func-
tions by level of care.
Denominator 
for indicator*
All formal facilities All facilities, per 10 000 population All surveyed facilities by level of care; availabil-
ity of EmOC is measured per 500 000 popula-
tion or 20 000 births*
Timeframe
15-18 months to complete fieldwork 
and report
Variable, but shorter than SPA or EmONC 12-18 months to complete field work and re-
port
Frequency 4-5 yearly intervals Designed to be repeated annually 4-5 yearly intervals
*Discussion is ongoing on whether denominator should measure births or population); expected number of births is the denominator for several oth-
er indicators – institutional birth rate, caesarean-section rate, met need for emergency obstetric care.
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Table 4 and Table 5 summarise the mapping of the 
interventions showing the structures and processes 
currently measured by the SPA, the SARA and the 
EmONC survey tools, and highlighting gaps in mea-
surement of structural and process domains.
For ease of presentation, and to avoid repetition, we 
summarise the findings from the review in this sec-
tion by structural and process domains.
Comparison of the matrix against 
health facility assessment tools and 
identification of gaps in measurement 
of the structural domain
Infrastructure
All three tools measured elements of general health 
facility infrastructure, such as electricity supply, 
means of communication, referral and transport 
and availability of water, toilets/latrines and waste 
disposal.
All tools measure availability of a table or surface for 
performing resuscitation. However, infrastructural 
requirements to support essential newborn care both 
in the labour and delivery room and the postnatal 
ward, such as space, privacy (screens) for mother to 
express breastmilk and infrastructure for storage of 
breastmilk (and whether there is consistent power 
supply for refrigeration) were not measured by any 
of the tools. All tools collect details on infrastructure 
to provide PMTCT.
The SPA measured space for mothers to provide kan-
garoo mother care (KMC) in its facility inventory, but 
only the EmONC assessment asked about space al-
location for sick newborn care or a special care unit 
(eg, infrastructure to provide services beyond KMC, 
such as assisted feeding, thermal protection, fluids 
and/or oxygen support). As oxygen is a crosscutting 
infrastructural component needed for several inter-
ventions outside of newborn health, all tools measured availability of an oxygen source. However, none 
of the tools measured the newborn-specific infrastructure that would be needed for safe oxygen therapy. 
Continuity of electricity and oxygen is especially important for facilities offering care for small and sick 
newborns who may be dependent on consistent oxygen source and/or electric equipment. None of the 
tools measured service readiness infrastructure for screening services (for example, developmental mile-
stones, hearing and vision) or follow-up for high-risk infants.
Table 4. A summary of the Service Provision Assessment (SPA), Service 
Availability and Readiness Assessment (SARA) and Emergency 
Obstetric and Newborn Care (EmONC) assessment tools’ capacity to 
measure structural and process domains of service readiness for 
newborn interventions in the labour and delivery room
InterventIon and components of structural domaIn health facIlItY assessment tool
SPA SARA EmONC
Immediate/essential newborn care:
Infrastructure Y Y Y
Equipment & drugs Y Y Y
Guidelines Y Y
Training Y Y Y
Routine practice Y Y Y
Thermal protection:
Infrastructure Y Y Y
Equipment & drugs
Guidelines Y Y Y
Training Y
Routine practice Y Y
Immediate and exclusive breastfeeding:
Infrastructure
Equipment & drugs Y
Guidelines Y Y
Training Y Y Y
Routine practice Y Y Y
Resuscitation with bag and mask:
Infrastructure Y Y Y
Equipment & drugs Y Y Y
Guidelines Y Y Y
Training Y Y Y
Routine practice Y Y Y
PMTCT if HIV-positive mother:†
Infrastructure Y Y Y
Equipment & drugs Y Y Y
Guidelines Y Y Y
Training Y Y Y
Routine practice Y Y Y
EmONC – Emergency Obstetric and Newborn Care, SPA – Service Provision As-
sessment, SARA – Service Availability and Readiness Assessment
*Y – measured by the tool.
†May only be applicable in settings with high HIV prevalence.
Table 5. A summary of the Service Provision Assessment (SPA), Service Availability and Readiness Assessment 
(SARA) and Emergency Obstetric and Newborn Care (EmONC) tools’ capacity to measure structural and process 
domain of service readiness for interventions in the newborn inpatient care unit
InterventIon and components of structural domaIn health facIlItY assessment tool
SPA SARA EmONC
Kangaroo mother care (KMC) including follow up:
Infrastructure
Equipment & drugs
Guidelines Y
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InterventIon and components of structural domaIn health facIlItY assessment tool
SPA SARA EmONC
Training Y Y
Routine practice Y Y Y
Alternative feeding if baby unable to breastfeed (cup feeding and nasogastric feeding):
Infrastructure
Equipment & drugs
Guidelines
Training
Routine practice Y
Safe administration of oxygen (including equipment for resuscitation):
Infrastructure Y Y Y
Equipment & drugs Y
Guidelines Y
Training Y
Routine practice Y
Intravenous fluids and management of hypoglycaemia:
Infrastructure
Equipment & drugs Y
Guidelines Y
Training Y Y
Routine practice Y Y
Injectable antibiotics for neonatal infection:
Infrastructure Y Y Y
Equipment & drugs Y Y Y
Guidelines Y Y Y
Training Y Y
Routine practice Y Y
Effective phototherapy:
Infrastructure
Equipment & drugs
Guidelines
Training
Routine practice
Seizure management:
Infrastructure Y Y Y
Equipment & drugs Y Y Y
Guidelines
Training
Routine practice
Continuous positive airway pressure and assisted/mechanical ventilation:
Infrastructure Y Y Y
Equipment & drugs
Guidelines
Training
Routine practice
Blood transfusion for newborns:
Infrastructure Y Y Y
Equipment & drugs
Guidelines
Training
Routine practice
Treatment and screening for retinopathy of prematurity:
Infrastructure
Equipment & drugs
Guidelines
Training
Routine practice
EmONC – Emergency Obstetric and Newborn Care, SPA – Service Provision Assessment, SARA – Service Availability and Readi-
ness Assessment
*Y – measured by the tool.
Table 5. Continued
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None of the tools measured advanced infrastructure for intensive care for very small and sick newborns, 
such as that required for mechanical ventilation, newborn blood and/or exchange transfusion, and spe-
cialist laboratory infrastructure beyond that needed for obstetric, and some paediatric and adult services.
Equipment
All tools measured provision of basic equipment for neonatal resuscitation, including smaller-sized face 
masks and resuscitation bag in the labour and delivery room. None of the tools measured whether resus-
citation equipment was available in the room where small and sick newborns are cared for to ensure safe-
ty and continuity of care.
Simpler interventions for small newborns, such as assisted feeding (plastic feeding cups and small sized 
nasogastric tubes) were only measured by the EmONC assessment, and hats or caps (including small siz-
es) are not consistently measured among the tools.
Phototherapy equipment needed to treat neonatal jaundice was only measured by the EmONC assess-
ment (fluorescent tubes and icterometry). Lower cost phototherapy technologies, such as LED photother-
apy devices were not included in any of the tools.
Although the infrastructure for oxygen was measured, most likely for paediatric and adult services, safe 
delivery of oxygen to newborns requires significant additional equipment items, such as newborn pulse 
oximetry, neonatal nasal prongs, oxygen-air blenders, low-flow metres and humidifiers, which were not 
captured by the tools.
Higher level respiratory support for newborns, such as Continuous Positive Airway Pressure (CPAP) ven-
tilation, was not measured by any of the tools. Our matrix shows that for safe delivery of CPAP, beyond 
the drivers themselves, facilities would require critical emergency equipment in case of pneumothorax 
such as transilluminators, chest tubes and valves.
Intubation equipment (eg, laryngoscopes blades in small sizes) were measured by the EmONC assess-
ment, but other critical components to support a ventilated newborn were not measured, including the 
ventilator machine.
Drugs
The EmONC assessment tool had the most extensive list of drugs and medicines for newborns detailing 
106 medicines and drugs for mothers and newborns, but very few of these are specified for newborns. 
There were several notable omissions of medicines for care at birth within the SPA and SARA, such as vi-
tamin K (SPA only asks whether it is routinely administered).
All three tools measured antibiotic drugs for treating small and sick newborn infections (amoxicillin oral 
and injection, ampicillin injection and gentamicin injection as a minimum). However, inventories did not 
specify whether the antibiotic was available in the injectable form, with the appropriate concentrations 
and diluents (usually water for injection, sodium chloride 0.9% and glucose 5%), or the availability of 
smaller intravenous cannulas/catheters and syringe drivers. The tools measured standard intravenous flu-
id preparations, but only EmONC included glucose 10%, which is most frequently used for neonates. 
For seizure management, only the EmONC tool measured the first and second line treatments (intrave-
nous phenobarbitone and phenytoin).
Several drugs that might be used for advanced level care, such as procedural sedation and pain relief, were 
not currently included in any of the tools.
In Table 2 we present an example drug list for inpatient care of small and sick newborns indicating which 
drugs are measured by each tool and whether these are on the most recent WHO model essential medi-
cines list [26]. This includes the commodities needed for retinopathy of prematurity screening and treat-
ment, such as dilating and anaesthetic eye drops, which are not currently included in existing tools.
Health providers
There were several notable gaps in measurement of specialist newborn staff. Only the EmONC tool mea-
sured specialist staff cadres for newborns (eg, neonatologist) and none of the tools measured specialist 
neonatal nurses. Allied staff and support staff (eg, social workers, speech therapist) were not measured. 
None of the tools measured ophthalmologists or related professions that are needed in settings where 
newborns may require screening and treatment for retinopathy of prematurity, or biomedical engineers 
for equipment maintenance.
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Guidelines
Table 1 shows all the guidelines and educational resources used for this review. Some resources cover a 
number of different interventions. However, there were notable gaps in available guidelines for more com-
plex interventions, such as continuous positive airway pressure, blood transfusion, exchange transfusion, 
ventilation, and treatment and screening of retinopathy of prematurity.
Identification of gaps in measurement of the process domain to capture 
service readiness to care for small and sick newborns for each intervention
Measurement of regular practice or training of health staff in specific interventions was considered as a 
proxy measurement for the process domain for service readiness as it looks at what is regularly done to 
patients in the institution.
Regular practice
All the tools relied on direct health worker reports, the register, or chart reviews to measure whether se-
lect interventions were regularly provided for small and sick newborns.
The SPA looked at whether a limited number of interventions relevant to newborns (neonatal resuscita-
tion and corticosteroids for preterm labour) were ever practiced and practiced in the last 3 months. The 
SPA also included a series of questions on essential care for newborns, but none on inpatient care for small 
and sick newborns, other than if KMC was practiced in the facility.
The SARA asked whether a limited number of functions were provided in the last 12 months: antibiotics 
for preterm or prolonged premature rupture of membranes, antenatal corticosteroids, neonatal resuscita-
tion, KMC, and injectable antibiotics.
The EmONC assessment had the most detailed list of newborn interventions for which questions on reg-
ular or recent practice were asked (newborn resuscitation, antenatal corticosteroids, antibiotics for preterm 
premature rupture of membranes, antibiotics for neonatal infections, KMC, administration of oxygen and 
administration of IV fluids).
The EmONC tool included specific knowledge questions on small and sick newborn care, including a 
few interventions, such as resuscitation, oxygen therapy and infections.
Table 6 summarises the approaches used by each of the tools to capture regular practice and training.
Table 6. The approach used by Service Provision Assessment (SPA), Service Availability and Readiness Assessment (SARA) and 
Emergency Obstetric and Newborn Care (EmONC) assessment to measure regular practice and training
spa sara emonc
regular practIce traInIng regular practIce traInIng regular practIce traInIng
Essential newborn care
Routinely 
practiced
Training in last 
24 months
Routinely 
carried out
Training in last 
24 months
Performed in last 3 
months
Ever received 
training
Thermal protection
Training in last 
24 months
As part of essential 
newborn care
As part of essential 
newborn care
Early initiation and support 
for exclusive breastfeeding
Routinely 
practiced
Training in last 
24 months
Routinely 
carried out
Training in last 
24 months
As part of essential 
newborn care
As part of essential 
newborn care
Neonatal resuscitation with 
bag and mask
Ever practiced, 
practiced in 
last 3 months
Training in last 
24 months
Practiced in 
last 12 months
Training in last 
24 months
Performed in last 3 
months
Ever received 
training
Prevention of mother to child 
transmission of HIV
Routinely 
practiced
Training in last 
24 months
Service is 
offered
Training in last 
24 months
ARVs given to newborns 
in the last 3 months
Ever received 
training
Kangaroo mother care Ever practiced
Training in last 
24 months
Practiced in 
last 12 months
Performed in the last 3 
months
Ever received 
training
Assisted feeding (cup feeding 
and nasogastric feeding)
Performed in last 3 
months
Safe administration of oxygen
Performed in last 3 
months
Injectable antibiotics for 
neonatal infection
Training in last 
24 months
Practiced in 
last 12 months
Performed in last 3 
months
Ever received 
training
Intravenous fluid
Training in last 
24 months
Performed in last 3 
months
EmONC – Emergency Obstetric and Newborn Care, SPA – Service Provision Assessment, SARA – Service Availability and Readiness Assessment
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The synthesis of these findings to provide recommendations on improving these measurements is pro-
vided in the Discussion section.
DISCUSSION
We have mapped the service readiness requirements for inpatient newborn care, detailing a total of 654 
structural components to deliver 17 newborn interventions. Our review of three health facility assessment 
tools identified measurement gaps for almost all newborn interventions, even for the more basic inter-
ventions, such as thermoregulation and feeding. The most significant measurement gaps are for more 
complex interventions, which are currently not captured by any of the tools in our review. We found many 
commonalities among these tools, but also highlighted important differences that show how they have 
evolved with important, but distinct purposes, and different measurement approaches [9]. The size and 
cost of these assessments already limits the frequency of carrying out these surveys; adding a long list of 
indicators for small and sick newborn care would compound this challenge [28]. To improve the existing 
tools, we found that a number of indicators for basic service readiness could be harmonised, and some 
proxy indicators of service readiness for more complex care could potentially be added. As with other 
more complex areas of care, monitoring all the structures and processes for small and sick newborns will 
likely require a facility-based monitoring system [29-31].
The existing, up-to-date care guidelines for inpatient care for small and sick newborns are mainly split 
between obstetric care and paediatric care (Table 2) [32-35]. To the best of our knowledge, this is the 
first time that service readiness for small and sick newborn care has been delineated and mapped by struc-
tural component. The resulting matrix can be used by implementers for programme planning, depending 
on the needs of their health system and the interventions or packages of care they intend to provide at 
their service (Table S1 in Online Supplementary Document). It is a step towards developing a more 
general facility based monitoring system or core module. Following validation, such a tool could be adapt-
ed for different settings as has been done in India [29].
The following sections provide a synthesis of findings and recommendations for improving the widely 
used tools for measurement of small and sick newborn care.
Harmonisation of existing health facility assessment tools
Indicators
The interventions that are best represented by the existing tools are those that have been promoted as 
vertical programmes, such as neonatal resuscitation (which is a core indicator for obstetric and newborn 
care assessments), essential newborn care (for all babies) and PMTCT. The measurement approach and 
indicators for many of the more basic newborn interventions would benefit from more standardisation 
between tools. As a minimum, this should include service readiness indicators for essential newborn care 
(including service readiness for drying, skin-to-skin contact, cord clamping, vitamin K and initiation of 
breastfeeding), neonatal resuscitation and kangaroo mother care [28].
All of the existing tools have some questions on KMC, but for monitoring of operational KMC [28], the 
facility inventories require adaptations to incorporate more of the items needed for KMC [23] including 
the equipment for feeding support, antibiotics and amenities for mothers to stay in the facility [14]. Whilst 
listing the items needed for antenatal care exceeded the scope of this exercise, these should be considered 
in future tools, such as availability of antenatal corticosteroids for threatened preterm labour and antibi-
otics for preterm rupture of membranes (per WHO guidelines) as a minimum.
Measurement of training and skills for newborn interventions could be harmonised between tools such 
that these indicators are comparable between different surveys (see Table 4).
Crosscutting service readiness needs
Health providers, especially midwives and specialist nurses, play a critical role in neonatal care [6,8,36-
38]. Specially trained neonatal nurses may not be available in all health facilities, but previous studies show 
it is important to monitor who, if anyone, cares for newborns in the absence of specialised staff [8]. Recent 
studies in higher income settings, where neonatal nursing is a specialist cadre, show that reducing the 
nurse-to-patient ratio in neonatal units increases in-hospital mortality [39,40]. As a minimum, all health 
facility assessment survey tools could include questions on staff rotation policies to ensure specialist staff 
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are not regularly being rotated to other areas of care [8], such a question is currently only included in the 
EmONC tool. Other allied and supportive professionals may be a necessary addition to the list of staff cad-
res, such as biomedical engineers for maintaining equipment and nursing support staff. For all health fa-
cility assessment tools, the capacity and readiness of a facility to provide referral to facilities that can pro-
vide more complex care for small and sick is a critical indicator of service readiness. The difficulty and 
inconsistency in measurement of provider skills and training also illustrates the need for further research 
into human resource tracking, and work to set benchmarks for staffing ratios for neonatal care [8].
Infection prevention and control is essential for all areas of the facility, with newborns particularly vul-
nerable, and most of the newborn deaths from infections occurring in small babies. The current tools 
have several general water and sanitation indicators, which should be harmonised across tools to ensure 
that the basic soap, running water and safe and effective antiseptics are available in labour and delivery 
and neonatal care areas. A standard indicator that measures whether the newborn space is separate from 
the paediatric ward, and for whether there is a system for inborn and out born babies could be a poten-
tial proxy indicator for service readiness.
Measuring more complex inpatient care for small and sick newborns
Small and sick babies, especially those born preterm, are at higher risk of multiple childhood morbidities 
(including visual, hearing and neuro-developmental), with increasing gradient of adverse developmental 
outcomes by lower gestational age of survivors [41,42]. These newborns often require more complex in-
terventions, such as respiratory support (oxygen, continuous positive airway pressure), treatment of spe-
cific complications (feeding, seizures, jaundice), and screening and follow up services (Figure 1) [8,43-
47]. Many of these interventions carry a risk of harm when not performed with safe equipment or by 
trained staff. This is illustrated in middle-income settings, where we have seen an increase in impairments 
among survivors of neonatal care, especially where complex care has been scaled up without due atten-
tion to service readiness and quality of care [41,42,48].
The existing tools do not capture the large number of items required to deliver complex interventions 
safely, which would require a facility based monitoring register that also includes process and outcome 
data (morbidity and mortality) [49]. Such registers have been developed in higher- and middle-income 
settings [29,49], but are not standardised routine systems. Further research into adaptations of existing 
tools is an important next step.
Clinical care charts and protocols are essential for quality and safety of neonatal care that requires com-
plex calculations of drug concentrations and specific diluents, dosages, and delivery modes for newborns. 
In addition to service readiness, the risks of certain interventions can be mitigated by ensuring clinical 
record keeping, which is known to be sub-standard in many settings [50]. Standardised observation charts 
for monitoring of vital signs (eg, hourly or three-hourly), fluid input and output, feeding method and 
volume, and monitoring medications and laboratory tests (eg, serum bilirubin and exchange transfusion 
thresholds) could support facilities, alongside up-to-date standardised evidence-based guidelines, a list 
of which is included in the documentation section of our matrix.
Implications and next steps for monitoring service readiness for inpatient 
care of small and sick newborns
Amongst existing partners and initiatives, there is widespread recognition of the need to harmonise mon-
itoring systems for perinatal care. The existing EmOC signal functions do not represent the full set of fa-
cility-based interventions for mothers and newborns, and small and sick newborns are especially neglect-
ed. Given the large number of service readiness requirements for small and sick newborn care, a short 
list of signal functions for monitoring purposes is a potential solution. Previous work by Gabrysch and 
colleagues has recommended improvements to these tools [51]. Currently, a global survey led by Every 
Newborn partners, alongside a technical group led by AMDD and UNFPA are working on linking this to 
the emergency obstetric care indicators, with plans to finalise recommendations for newborn signal func-
tions in 2018-2019 [9].
Periodic evaluation, using health facility surveys, is currently necessary, but ultimately the goal should be 
to incorporate such assessments into functional and sustainable routine national systems. These should 
operate independent of donor funding and project mandates. The current health facility assessment tools 
are costly and time-consuming. Lighter assessments that can be carried out more frequently are also re-
quired, and need more research [52]. Even in high-income countries, not all national facilities feed infor-
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mation into one database for national monitoring of inpatient care of small and sick newborns. Low- and 
middle-income countries that have not moved to electronic information systems have an advantage in 
that they can leap-frog the situation of having fragmented and discrepant electronic data collection forms 
which differ from facility to facility or region to region. Exploration of the potential use of DHIS-2 plat-
forms for facility-based monitoring is being carried out as part of the Every Newborn metrics work on 
small and sick newborns [9]. This work supports the growing interest in use of routine health manage-
ment information systems to monitor aspects of service delivery in facilities [14], and of logistic manage-
ment information systems (LMIS) to track logistics and supplies.
CONCLUSIONS
Tracking of service readiness to provide inpatient care of small and sick newborns is needed to gain the 
required policy attention, accountability and investment that is critical to end preventable newborn deaths, 
and improve child development. This is reflected in the Global Strategy for Women, Children and Ado-
lescents, the WHO Quality of Care Framework, and is supported by the Every Newborn metrics working 
group. The existing health facility assessments do not generate comparable data, and have very limited 
assessment of more complex care for small and sick newborns. Indicators in existing tools can be har-
monised, but the size and cost of these assessments limits their frequency. Developing a core list of har-
monised indicators for use in routine health information systems could help address this gap. Improve-
ments in these monitoring systems are urgently needed to inform efforts to improve quality of care and 
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